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Biological sterilization represents one of the most exciting applications of atmospheric pressure
glow discharges APGD. Despite the fact that surgical instruments are contaminated by both
microorganisms and proteinaceous matters, sterilization effects of APGD have so far been studied
almost exclusively for microbial inactivation. This work presents the results of a detailed
investigation of the capability of a helium-oxygen APGD to inactivate proteins deposited on
stainless-steel surfaces. Using a laser-induced fluorescence technique for surface protein
measurement, a maximum protein reduction of 4.5 logs is achieved by varying the amount of the
oxygen admixture into the background helium gas. This corresponds to a minimum surface protein
of 0.36 femtomole/mm2. It is found that plasma reduction of surface-borne protein is through
protein destruction and degradation, and that its typically biphasic reduction kinetics is influenced
largely by the thickness profile of the surface protein. Also presented is a complementary study of
possible APGD protein inactivation mechanisms. By interplaying the protein inactivation kinetics
with optical emission spectroscopy, it is shown that the main protein-destructing agents are excited
atomic oxygen via the 777 and 844 nm emission channels and excited nitride oxide via the 226,
236, and 246 nm emission channels. It is also demonstrated that the most effective protein
reduction is achieved possibly through a synergistic effect between atomic oxygen and nitride oxide.
This study is a useful step toward a full confirmation of the efficacy of APGD as a sterilization
technology for surgical instruments contaminated by prion proteins. © 2007 American Institute of
Physics. DOI: 10.1063/1.2717576
I. INTRODUCTION
While the use of ionized gases as a microbiocidal agent
was first reported in 1968, their potential as a genuine ster-
ilization technology has attracted serious and widespread at-
tention only over the past 10 years. One of the key stimuli
has been the increasing inadequacy of conventional hospital
procedures for inactivation of prion proteins and for steril-
ization of tubular instruments such as endoscopes. Widely
regarded as the etiologic agent of spongiform neurodegen-
erative pathologies such as bovine spongiform encephalopa-
thy BSE, scrapie, and Creutzfeldt-Jakob diseases CJD,1
prion proteins are extremely resistant to all current hospital
decontamination procedures including autoclaving, ionizing
radiation, and formaldehyde.2 As a consequence, there is an
urgent and fundamental need for new and effective prion
inactivation strategies. The advent of atmospheric pressure
glow discharges APGD Ref. 3 offers an exciting oppor-
tunity for prion inactivation with the advantage of minimiz-
ing the environmental burden of wet chemistry. Operating
typically in open air without a vacuum chamber, APGD pro-
duce large fluxes of energetic and highly reactive plasma
species such as UV photons, charged particles, and reactive
oxygen species, all of which can potentially cause damage to
both microorganisms and proteinaceous matters. So far, the
bio-decontamination effect of APGD has been examined al-
most exclusively for microbial inactivation, in which case
they have been shown comprehensively to be capable of in-
activating wide-ranging microorganisms including the veg-
etative cells of yeast and bacteria, viruses, bacterial spores,
and even biofilm-forming bacteria.4–8 A great deal has been
learned about how APGD inactivation depends on the
plasma operating conditions9,10 and the physiology of the
microbial population.11,12 These studies have helped estab-
lish convincingly the microbiocidal capability of APGD. To-
day, atmospheric pressure glow discharges are widely re-
garded as one of the most exciting technology platforms that
is likely to impact profoundly on the bio-decontamination
practice and policy in both the healthcare service and the
food industry.4,8
Much less known is the capability of APGD for inacti-
vation and destruction of proteinaceous matters,13,14 even
though surgical instruments are usually contaminated by
both bacteria and proteins. This lack of understanding is of
great concern, given the considerable risks of prion contami-
nation of surgical instruments to many patients, particularly
those who require neurosurgery. For the APGD technology
to become a genuine sterilization solution for the healthcare
service, it is essential to study and develop its capability for
protein inactivation. In this article, we present a detailed in-
vestigation of protein destruction using an APGD jet in
helium-oxygen flow in order to a establish the protein in-
activation capability of atmospheric pressure glow dis-
charges and b offer insights into possible mechanisms of
plasma protein destruction. In Sec. II, materials and methodsaCorresponding author; electronic mail: m.g.kong@lboro.ac.uk
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used in this study are reviewed with an emphasis on both the
APGD jet system employed and the measurement of protein
deposited on solid surfaces. This is followed in Sec. III by a
systematic investigation of protein inactivation using protein
reduction kinetics analogous to those used in microbial
inactivation.15 Given the current interests in and uncertainties
of plasma inactivation mechanisms, we also include in Sec.
IV a first study of possible protein-inactivating plasma spe-
cies with a view to ultimately unravel APGD protein inacti-
vation mechanisms. Our strategy is to exploit possible corre-
lations of the protein reduction kinetics to the relative
densities of key plasma species. Finally, in Sec. V, findings
of this study are summarized and important issues for the
future development of the APGD protein inactivation tech-
nology are discussed.
II. MATERIALS AND METHODS
The atmospheric pressure plasma system used in our
study was a cold atmospheric plasma jet struck inside a
helium-oxygen channel and ejected into the ambient air. As
shown in Fig. 1, the gas channel was formed by flushing a
helium-oxygen gas mixture through a ceramic tube around
which a metallic strip of 10 mm wide was wrapped as the
powered electrode. The inside and outside diameters of the
ceramic tube were 1.5 and 2 mm, respectively, and the ce-
ramic tube was enclosed inside a PTFE hosting unit. The
grounded electrode was a dielectrically insulated metal plate,
and was placed downstream about 2–20 mm away from the
nozzle of the ceramic tube. Depending on the applied voltage
and the gas flow rate, the plasma jet was about 10–40 mm in
length and 2–3 mm in diameter. Details of the plasma jet
have been given elsewhere.17,18 For this study, the APGD jet
was energized with a sinusoidal voltage source with a peak
voltage of 4–8 kV and an excitation frequency of 30–45
kHz. Helium 99.9999% was used as the working gas with
its flow rate fixed at 5 slm, either alone or mixed with oxy-
gen gas of varying flow rates. An auxiliary oxygen flow,
marked as the side O2 in Fig. 1, was sometimes introduced
into the ceramic tube at a downstream entrance from the
powered electrode. For experiments reported here, the en-
trance of the side O2 flow was fixed at 3 mm away from the
nozzle-side edge of the powered electrode. The purpose of
this side O2 flow was to make available more ground-state
oxygen molecules. The APGD jet system separated the
helium-dominating plasma generation region from the treat-
ment region where air chemistry was introduced. Because of
its capability for more active plasma chemistry, it was se-
lected instead of one with the usual parallel-plate configura-
tion.
At present, standard hospital sterilization procedures
such as autoclaving are used in medical sterilization units to
clean and sterilize surgical instruments. Autoclaving proce-
dures are very effective in washing off large quantities of
tissue fragments and other organic matters left on medical
devices following surgeries. Unfortunately, they often leave
small amount of protein residues on surgical instruments,
and the autoclaved protein residues tend to attach tightly to
the surfaces of the instruments.16 These protein residues are
the source of cross contamination.1 Therefore, any plasma
protein inactivation strategy is perhaps best introduced as an
additional step in the decontamination process after the au-
toclaving cycle. Given that protein deposits following the
autoclaving procedure tend to be localized and their size
tends to be small,16 the APGD jet of Fig. 1 is appropriate.
Given the highly infectious nature of prion proteins, our
study employed bovine serum albumin BSA as a model
protein, purchased from Sigma-Aldrich Dorset, UK. To
model surgical instruments, stainless-steel disks of 6 mm di-
ameter were made and used as the sample substrate. Ex-
amples of such disks are shown in the inset of Fig. 1. Quan-
tities of BSA, up to 20 l per droplet, were diluted in
distilled water and then their droplets were deposited on
stainless-steel surfaces to dry at 50 °C before plasma treat-
ment. The diameter of the BSA deposit on the stainless-steel
disk was typically 5 mm. All data of plasma protein inacti-
vation experiments were in triplicate from three independent
experiments.
The discharge current and the applied voltage were mea-
sured by a wideband current probe Tektronix P6021 and a
wideband voltage probe Tektronix P6015A, respectively,
and their waveforms were recorded on a digital oscilloscope
Tektronix TDS 3034B. Optical emission spectrum from the
APGD jet was obtained using a spectrometer system Andor
Shamrock with a focal length of 0.3 m and a grating of 600
grooves/mm. The spectral measurement was taken from the
contact point of the plasma jet with the sample surface. To
assess the efficacy of the plasma protein inactivation, it is
important to quantitatively measure surface-borne protein,
before and after plasma treatment. While standard biology
laboratory methods, such as spectrophotometers, can be used
to reliably measure protein in suspension, they cannot be
used directly for measurement of surface-borne protein.
Since no established devices are commercially available for
measurement of surface-borne protein, we employed a laser-
induced fluorescence technique LIF,19 and developed an
FIG. 1. Color online Schematic of the atmospheric-pressure He-O2 plasma
jet with its connection to the external circuit and an image of the stainless-
steel disk samples. The APGD jet is struck inside a ceramic tube and the
ceramic tube is enclosed inside a PTFE hosting unit shown as the gray
object in the background.
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optical system to quantitatively detect proteinaceous matters
on stainless-steel surfaces. Specifically, the BSA sample was
labeled with FITC fluorescein isothiocyanate through cova-
lent binding.19,20 With appropriate light irradiation, the FITC-
labeled protein fluoresces and the fluorescence intensity can
be correlated with the amount of the surface protein thus
offering a means of protein detection. The schematic of the
laser-induced fluorescence apparatus is shown in Fig. 2a,
with the inset being an example of the FITC-labeled BSA
under laser irradiation. The optimum excitation wavelength
for the fluorescence was 488 nm and the maximum fluores-
cence emission was around 530 nm.
The excitation signal was provided by a laser-emitting
diode Ocean Optics LS 475 with a signal bandwidth of
460–490 nm. Wavelength filtering was found critical to re-
duce signal interference and extend the detection limit. Inter-
ference from reflected excitation light from the stainless-steel
surface was effectively removed by the emission filter Thor-
labs, FEL0500. Another source of interference was Raman
scattering,20 particularly when the deposited protein was at a
sufficiently low level. This was generated in the excitation
fiber at about 430 nm and reflected by the stainless-steel
surface into the emission fiber at about 470 nm.20 However
the reflected Raman scattering signal had a long tail extend-
ing into 480–580 nm and overlapping the fluorescence signal
at 530 nm. To overcome this, we employed both the dichroic
filter a 505 nm Nikon filter and the exciter filter La-
ser2000, FF506-Ex04–25 to minimize the Raman scattering
signal, similar to the technique reported in the literature.20
With these wavelength filters, a linear correlation was found
to exist between the surface-deposited BSA protein and the
fluorescence intensity from 55 picomole to 6.7 femtomole
as shown in Fig. 2b. Given that the surface area of the
BSA deposit was about 4.9 mm2, the above minimum
suggests a detection limit of 1.4 femtomole/mm2 or 1.4
109 molecules/mm2. It is worth mentioning that the fluo-
rescence quenching of molecules in close proximity to metal
surfaces was considered, with the main effect being a reduc-
tion of about 60% in the quantum yield of the fluorescence
compared to that in solution.20 To ensure that this has been
accounted for accurately, we calibrated the results of the LIF
method in Fig. 2 against those obtained from a photon count-
ing fluorescence spectrometer Jobin-Yvon-Horiba
Fluoromax-Pro. This has confirmed that the LIF system in
Fig. 2a offers a quantitative means to measure surface-
borne protein reliably and accurately.
III. PROTEIN REDUCTION KINETICS
BSA-laden stainless-steel samples were plasma-treated
over different periods of time after which surface proteins
were measured using the laser-induced fluorescence tech-
nique of Fig. 2. The relationship of residual BSA proteins on
the stainless-steel surface to the plasma treatment time is
effectively the protein reduction kinetics, very similar to the
microbial inactivation kinetics.15 Effects of different plasma
parameters were studied, of which the most important were
1 the peak applied voltage, Vp; 2 the distance from the
nozzle of the ceramic tube to the sample, dns; 3 the flow
rate of the oxygen gas added to the helium flow through the
powered electrode; and 4 the flow rate of an auxiliary oxy-
gen gas introduced downstream from the powered electrode
see Fig. 1. These parameters were considered because they
are likely to significantly affect the plasma chemistry at the
point of the protein sample and hence protein reduction. For
example, the applied voltage influences directly the level of
the gas ionization and hence the production of reactive
plasma species. As all plasma species have a finite life, the
nozzle-to-sample distance is likely to alter the concentration
of plasma species at the sample point and hence their effi-
ciency for protein reduction. On the other hand, reactive oxy-
gen species are known to play a dominant role for plasma
microbial inactivation.21 Therefore, it is desirable to add the
oxygen gas into the working gas to provide an additional
source for reactive oxygen species. For future reference, the
oxygen gas added to the He flow through the powered elec-
trode is referred to as the central O2 flow and the auxiliary
oxygen gas introduced downstream from the powered elec-
trode is referred to as the side O2 flow. The central O2 flow is
introduced for direct ionization within the ceramic tube by
the applied voltage, and the side O2 flow is intended as an
additional oxygen source to be exited and/or ionized by en-
ergetic and long-life helium metastables. Atomic helium
metastables He 2s 1S0 and He 2s 3S1 are produced with
excitation energy of 20.61 and 19.82 eV, respectively, both
greater than the ionization energy of oxygen at 13.62 eV. So,
He 2s 1S0 and He 2s 3S1 metastables are capable of ion-
izing ground-state oxygen molecules in the ambient air.
Here, we consider in turn the effects of the above four dif-
ferent parameters.
FIG. 2. Color online a Schematic of the laser-induced fluorescence LIF
system for surface protein measurement with the inset being the fluores-
cence image of a protein contaminated stainless-steel sample; b the linear
dependence of the surface protein on the fluorescence intensity.
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A. Effects of the applied voltage
and the nozzle-sample distance
With dns fixed at 10 mm, pure helium was first used as
the working gas and fed through the ceramic tube for ioniza-
tion. As the applied voltage was increased, the plasma jet
became brighter and its length became longer images not
shown. This suggests that larger fluxes of excited species
were produced at higher levels of the applied voltage. Figure
3a shows protein reduction kinetics at different peak values
of the applied voltage, for which the control experiment was
performed in a 5 slm helium flow with the plasma off. It is
evident that the 5 slm helium flow with the APGD turned off
led to negligible protein removal. It is also evident that
greater protein reduction was achieved at larger applied volt-
age. This is in a broad agreement with the large fluxes of
excited plasma species produced at larger applied voltage.
For our experiments, the maximum peak applied voltage was
limited at 8 kV, beyond which the plasma jet started to heat
up the protein sample. Figure 3b shows protein reduction
kinetics at different values of dns with Vp=8 kV and again
pure helium as the working gas. Protein reduction is seen to
be the most effective at a nozzle-to-sample distance of 10
mm. As oxygen-exciting and/or oxygen-ionizing agents are
ejected out of the ceramic tube by the plasma jet, they are
likely to reduce in both their energy and concentrations after
a critical nozzle-to-sample distance. It is therefore conceiv-
able that protein reduction becomes less effective when dns is
too long. If the nozzle-to-sample distance is too short, on the
other hand, ground-state oxygen molecules outside the tube
nozzle are likely to be pushed away from the sample region
by the high-speed ejecting plasma jet. This reduces the
amount of available oxygen molecules that can be excited
and/or ionized near the protein sample, thus compromising
protein reduction. From Fig. 3, the optimum plasma condi-
tion appears to be Vp=8 kV and dns=10 mm. These are used
for our studies below.
B. Effects of the central O2 flow rate
With the rate of the central oxygen flow increasing from
zero to 100 sccm, the protein reduction kinetics changed
considerably as shown in Fig. 4a. The control experiment
included in Fig. 4a was performed with the plasma off in an
un-ionized helium-oxygen flow for which the helium and
oxygen flow rates were at 5 slm and 25 sccm, respectively. It
is shown in Fig. 4a that the un-ionized He-O2 flow had a
negligible effect on protein removal. The most effective pro-
tein reduction is seen to occur at a central O2 flow rate of 25
sccm. To compare different cases more clearly, we introduce
two quantification parameters of a the plasma treatment
time to achieve one log protein reduction, or the D value,15 at
the beginning of the plasma treatment; and b the final
amount of protein residue after 300 s of the plasma treat-
ment. These represent the initial protein reduction rate and
the total accumulated protein reduction, respectively. As the
D value is calculated at t=0, it is likely to reflect directly the
effect of the most lethal plasma species. Figure 4b suggests
that the shortest D value was 88 ms per picomole over a
wide flow rate range of 5–50 sccm, suggesting the persis-
tence of the most lethal plasma species in this flow rate
range.
FIG. 3. Color online Protein reduction kinetics with the APGD jet in a 5
slm pure helium flow a at dns=10 mm and different applied voltages; and
b at different tube-to-sample distances and Vp=8 kV. The control experi-
ment in a was done in a 5 slm helium flow with the plasma off and dns
=10 mm.
FIG. 4. Color online Effects of the central O2 admixture as shown in a
protein reduction kinetics and b the O2 flow rate dependence of the BSA
residue and the D value. No side O2 flow. The control experiment in a was
done in a He-O2 flow He: 5 slm; O2: 25 sccm with the plasma off and
dns=10 mm.
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Figure 4b also suggests that the lowest final protein
residue was 35 femtomoles at a central O2 flow rate of 25
sccm. The existence of an optimal flow rate may be inter-
preted as follows. When the central O2 flow rate is too low,
less than 25 sccm in our case, the available oxygen mol-
ecules in the He-O2 working gas are insufficient for the
maximum oxygen excitation and/or ionization to be reached
at a given peak applied voltage of Vp=8 kV. As a result, the
production of reactive oxygen species is not the most effec-
tive and the resulting protein reduction is also below optimal.
If the central O2 flow rate is too large, more than 25 sccm in
our case, the oversupply of available ground-state oxygen
molecules increases the breakdown voltage of the He-O2
working gas and so decreases the level of the gas ionization
at Vp=8 kV. This compromises the production of reactive
oxygen species at the sample point and in turn reduces the
efficiency of protein inactivation. It is conceivable that the
final protein residue is the combined results of many differ-
ent plasma species accumulated over a given period of time.
The observation in Fig. 4b of its clear minimum at 25 sccm
suggests that some of the less lethal plasma species may
have worked synergistically with the most lethal species to
cause a sharp protein reduction at 25 sccm.
C. Effects of the side O2 flow
The clear protein reduction with pure helium in Fig. 3
suggests that it is possible for reactive oxygen species to be
produced outside the plasma generation zone in a down-
stream region where energetic helium metastables and
charged particles excite and/or ionize ground-state oxygen
molecules in the ambient air. It is therefore of interest to
examine whether a greater protein reduction can be achieved
by making available of more ground-state oxygen molecules
at a downstream point. To this end, the side O2 flow was
introduced and the resulting protein reduction kinetics ob-
tained is shown in Fig. 5a. Again, the D value and the final
protein residue are used here to quantify the effects of the
side O2 flow. As shown in Fig. 5b, the introduction of the
side oxygen flow tends to compromise protein reduction and
is in general undesirable. Although the exact reason is un-
clear for the observed negative results, it is possible that the
side-fed oxygen gas may have overly diluted the concentra-
tions of helium metastables and/or electrons. Further para-
metric studies are of interest, but are best carried out in a
separate study.
D. Plasma conditions for effective protein reduction
Together with the earlier discussion of Fig. 4, it is clear
that the optimal protein reduction is achieved with no side O2
flow and with a central O2 flow at 25 sccm. Figures 4 and 5
have therefore clearly established the protein reduction capa-
bility of atmospheric pressure glow discharges in general and
the APGD jet of Fig. 1 in particular. The minimum protein
residue after plasma treatment in our experiments was 35
femtomoles or 7.1 femtomoles/mm2. It is possible to reduce
this further using, for example, different gases,6,7,20 different
temporal features of the electrical excitation,10,18,22 and in-
deed different APGD configurations.5,23 A related issue is
whether a minimum protein residue of 7.1 femtomoles/mm2
is acceptable for plasma-treated surgical instruments to be
reused, and indeed what the acceptable minimum of protein
residue may be. At present, these questions remain unan-
swered and the ultimate answer lies in a thorough bioassay
study. It is however important to emphasize that protein in-
fectivity depends not only on the amount of protein residue
but also their biological characters. In a very recent study, we
used electrophoresis experiments to demonstrate that protein
matters remaining on their substrate surface following
plasma treatment sustained considerable degradation.14
Therefore, even when plasma treatment cannot completely
remove all proteinaceous matters from stainless-steel sur-
faces, the plasma-treated but unremoved proteins are likely
to have a compromised integrity and perhaps a reduced in-
fectivity, thus posing less risk than untreated proteins.
IV. PROTEIN REDUCTION MECHANISMS
Protein reduction kinetics in Figs. 4a and 5a exhibits
two phases—an initial rapid reduction and then a much
slower reduction over an extended period of time. Under
plasma conditions not discussed here, it is possible for an
additional phase to appear between the initial phase and the
final extended phase, thus exhibiting three phases. These
phases appear to represent different modes of protein inacti-
vation. Although this is very similar to microbial inactivation
by APGD,15 the underlying reasons may not necessarily be
the same. In the case of microbial inactivation, different
FIG. 5. Color online Effects of the side O2 admixture as shown in a
protein reduction kinetics and b the O2 flow rate dependence of the BSA
residue and the D value. The central O2 flow rate is fixed at 25 sccm and the
helium rate is at 5 slm.
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modes of the microorganism resistance to plasma treatment
can be a result of many different factors including the cell
wall,4,6 phase of cell growth,12 and cell stacking.17 To under-
stand the factors that contribute to the essentially biphasic
kinetics of plasma protein reduction, we took fluorescence
images of the FITC-labeled protein sample after different
plasma treatment times. These are shown in Fig. 6 together
with the protein reduction curve under the optimal conditions
of Vp=8 kV, a central O2 flow rate of 25 sccm, and a side O2
flow rate of 0 sccm. It is clear that the first 30 s of the plasma
treatment were effective in removing the central region of
the protein deposit. By contrast, the edge region of the pro-
tein deposit was far more difficult to remove and required
further 270 s to substantially reduce the protein fluorescence
signal. Close evaluation of the protein-laden stainless-steel
disks revealed that the protein deposit was thin in its middle
and thick in its edge data not shown. Therefore, the bipha-
sic character of the protein reduction kinetics is largely re-
lated to the thickness profile of the surface protein, similar to
the microbial loading effect in plasma bacterial
inactivation.11 One important implication of this finding is
that a more efficient protein removal would be achieved if
localized protein deposits on surgical instruments could be
identified, using fluorescence techniques for example, for
them to be specifically treated by the APGD jet.
Efficiency of protein reduction can be improved if the
most lethal plasma species are identified. Factors responsible
for protein reduction usually fall into five categories, namely
1 heat; 2 charged particles; 3 intense electric field; 4
UV photons; and 5 neutral reactive species, all commonly
present in a gas discharge. These are known to contribute to
microbial inactivation by APGD,21 and could potentially be
responsible for protein reduction observed in Figs. 4 and 5.
For example, the electric field in the sheath region of APGD
can be as high as 100 kV/cm Ref. 24 and may cause an
irreversible damage to protein.25,26 However, with our APGD
jet configuration, the protein reduction took place at a down-
stream point away from the plasma generation region and
away from the APGD sheath region. Therefore, the contribu-
tion of the electric field is likely to be very small, though this
has yet to be confirmed by direct measurement of the electric
field. To establish the contribution of heat and UV photons,
we measured the temperature of the protein substrate as a
function of plasma treatment time for the He+O2 case with
the central O2 flow rate being 25 sccm. As shown in Fig.
7a, the highest temperature reached was 40 °C. To show its
effect, we used an un-ionized He+O2 flow with the electri-
cal power switched off to treat a protein sample that was
kept at a constant temperature of 40 °C. No protein reduc-
tion was observed after 300 s of the treatment. With the
sample unheated but with the He+O2 gas ionized at Vp
=8 kV, surface-borne BSA was found to reduce from 55 pi-
comoles to 35 femtomoles over 300 s. It is therefore clear
that heat generated in our APGD jet had a negligible protein
reduction effect. To investigate the effect of UV, we em-
ployed a commercial UV lamp Ultra Violet Products Ltd,
Cambridge, UK with its wavelength at 254 nm and its
power consumption at about 2 W. After 300 s of the UV
treatment, protein reduction was a very limited 3 picomoles
from an initial 55 picomoles as shown in Fig. 7b. We also
employed an UV passing glass Thorlabs to cover the pro-
tein sample so that only light of 170–400 nm could pass
through.21 The achieved reduction was about 7 picomole
over 300 s, still much smaller than the 3 log reduction seen
in Fig. 7a. It is therefore clear that both heat and UV pho-
tons were unlikely to be responsible for a significant protein
reduction in our experiments.
Excited-states reactive plasma species can be detected
with optical emission spectroscopy. Figure 8 shows the opti-
cal emission spectrum of the APGD jet of Fig. 1, taken near
the sample point and at a central O2 flow rate of 25 sccm. It
is clear that they exhibit strong emission lines of helium
species as well as UV, OH radicals, oxygen species, and
nitrogen species. The presence of the oxygen and nitrogen
species was a result of the fact that the APGD was ejected
into the ambient air where its energetic electrons and meta-
FIG. 6. Color online Reduction kinetics of surface protein with the fluo-
rescence images of the BSA-contaminated sample after 0, 5, 30, 120, 240,
and 300 s of the APGD treatment. Conditions are Va=8 kV, the central O2
flow rate =25 sccm, and the side O2 flow rate =0 sscm.
FIG. 7. Color online a Protein reduction black, circles and the sample
temperature red, diamonds as a function of the treatment time, together
with the control of an un-ionized He-O2 gas flow black, squares; b pro-
tein reduction by UV photons produced by the plasma jet black, squares
and a commercial UV lamp red, circles.
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stables ionized and excited air molecules.18,21 The three
strongest helium lines are at 587, 668, and 706 nm. In the
200–300 nm region, there is one strong UV line at 297 nm
and five excited nitride oxide NO lines at 226, 236, 246,
270, and 283 nm. Nitrogen lines dominate the 300–400 re-
gion with the signatures of the excited N2 species at 316,
337, 354, 357, 358, and 380 nm, whereas the OH lines are
seen at 309, 614, and 616 nm. Oxygen lines are the most
numerous. Apart from the metastable oxygen molecule line
at 760 nm, there are at least seven atomic oxygen lines at
615, 645, 700, 725, 777, 794, and 844 nm. The underpinning
plasma chemistry is therefore rather complex.
To study possible correlations of the reactive plasma
species to the observed protein reduction, optical emission
spectra at different rates of the central oxygen flow were
measured for comparison with the protein inactivation kinet-
ics of Fig. 4b. As shown in Fig. 9a, NO line intensities at
270 and 283 nm and the UV line intensity at 297 nm reduce
with increasing flow rate of the central O2 flow, and so do
not correlate to the O2 rate dependence of the protein reduc-
tion in Fig. 4b. On the other hand, emission intensities of
the three short NO lines at 226, 236, and 246 nm increase
with the O2 rate and appear to relate to the trend of the
protein reduction in Fig. 4b. It is in fact intriguing to ob-
serve the similar plateaus, over the 10–50 sccm range, in the
O2 rate dependence of the D value see Fig. 4b and in that
of the line intensities at the three short NO wavelengths see
Fig. 9a. However, this is contradictory to the results of
Fig. 7b, where the role of UV seems very small. This sug-
gests that nitride oxide may have contributed to the protein
reduction of Fig. 4b but may have done so after initial
protein damage by other plasma species.
As the central oxygen flow rate increased, the optical
emission intensities of all excited nitrogen lines at 316, 337,
354, 357, 380, and the N2+ line at 358 nm were found to
reduce as seen in Fig. 9b. Therefore, nitrogen metastables
and nitrogen ions do not appear to correlate to the protein
reduction in Fig. 4. Similarly, the optical emission intensities
of the three OH lines at 309, 614, and 616 nm have a de-
creasing dependence on the O2 flow rate in Fig. 9c, sug-
gesting that OH radicals are unlikely to play a dominant role
in the protein reduction of Fig. 4. Reduction in the emission
intensities of the three helium lines 587, 668, and 706 nm is
a result of an increased breakdown voltage with an increas-
ing oxygen admixture in the working gas and hence a de-
creased level of gas ionization.
Figure 9d shows the trend of the metastable oxygen
molecules, O21g
+, at 760 nm and the excited oxygen atoms
at seven wavelengths e.g., 615, 645, 700, 725, 777, 794, and
844 nm. Compared to the pure-helium case, for which the
central oxygen flow rate is zero, the line intensities at 777
and 844 nm are stronger in the 5–10 sccm range and the
5–23 sccm of the central O2 flow rate, respectively. All other
FIG. 8. Optical emission spectra of the APGD jet near the sample point with
Va=8 kV, no side O2 flow, and a central oxygen flow rate of 25 sccm.
FIG. 9. Color online Percentage
changes in the line intensities of a
UV and nitride oxide in the 200–300
nm region; b nitrogen species; c
OH radicals and excited helium spe-
cies; and d excited oxygen species,
all with Va=8 kV and no side O2 flow.
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lines in Fig. 9d reduce with increasing oxygen flow rate.
Therefore, the excited oxygen atoms associated with the
emission channels at 777 and 844 nm have a similar O2
dependence to that of the protein reduction in Fig. 4b, and
as such may be responsible for the observed protein reduc-
tion. It is worth emphasizing that the O2 rate range of 5–23
sccm in which the line intensities at 777 and 844 nm are
large in Fig. 9d is smaller than the O2 rate range of 5–50
sccm in which the D value is close to its minimum in Fig.
4b. We also notice that the NO line intensities at 226, 236,
and 246 nm are always stronger than those in the pure he-
lium case over a very large range of 5–100 sccm in the
central O2 flow rate. It is therefore probable that protein re-
duction observed may be caused by both atomic oxygen and
nitride oxide. More specifically, we speculate that for the
5–23 sccm range the excited-state oxygen atoms cause an
initial degradation to the surface-borne protein and help in-
crease the subsequent damage by the excited nitride oxide
species. This synergistic effect is stronger in the 5–15 sccm
range in which the dosage of excited NO species is below
optimal, with the line intensity at 246 nm reducing and with
the intensity at 226 nm yet to reach its maximum.
For the O2-rate range of 50–100 sccm, all excited oxy-
gen lines are of lower emission intensities than their values
in the pure helium case. Although the three short NO wave-
lengths are seen in Fig. 9a to maintain their levels at 50
sccm, the low protein reduction efficiency above 50 sccm in
Fig. 4b suggests that protein destruction by NO alone is
ineffective. By considering the two O2-rate ranges of 5–23
and 50–100 sccm, the comparison of optical emission spectra
and protein reduction kinetics supports strongly a synergistic
effect between atomic oxygen and excited nitride oxide. This
synergistic effect is further supported by the sharp minimum
of the final protein residue at 25 sccm, even though the O2
rate of 25 sccm is just outside the 5–23 sccm range. It is
worth mentioning that the correlation between optical emis-
sion spectra and protein reduction kinetics is less obvious for
atomic oxygen and excited nitride oxide in the 23–50 sccm
range. Therefore, other reactive plasma species not shown in
Figs. 8 and 9 may have also contributed to the persistently
low D value in the 23–50 sccm range and to the sharp mini-
mum of the final protein residue at 25 sccm. These may
include ground-state atomic oxygen, ground-state nitride ox-
ide, and ozone. We are currently developing their measure-
ment techniques and will report their effects in a future note.
V. CONCLUDING REMARKS
In this contribution, we have attempted to answer two
questions—whether atmospheric pressure glow discharges
can destruct surface-borne proteins and, if so, what the pro-
tein destruction mechanisms may be. By using a helium-
oxygen APGD jet, we have shown that surface protein can be
reduced significantly. Electrophoresis experiments reported
in our previous study suggest that protein residue left on the
stainless-steel surface after APGD treatment has sustained
considerable degradation.14 It is conceivable that protein re-
moved from the stainless-steel surface by APGD treatment is
likely to sustain even greater damage. Therefore, protein re-
duction observed is through destruction and degradation.
Even if plasma treatment cannot completely remove all pro-
teinaceous matters from stainless-steel surfaces, the plasma-
treated but unremoved proteins are likely to have compro-
mised integrity and possibly reduced infectivity, thus posing
less risk than untreated proteins. Clearly, this adds a signifi-
cant benefit to the capability of any APGD-based protein
inactivation technology.
Kinetics of APGD protein reduction is typically bipha-
sic, strongly affected by the thickness profile of the surface
protein. It is however worth mentioning that the time scale of
the initial phase of rapid protein reduction is shorter than the
time scale over which the central region of the protein de-
posit is removed see Fig. 6. This indicates the possibility of
an additional factor, for example from the different time
scales at which different plasma species damage the surface
protein. Using the LIF protein detection system of Fig. 2
with a detection limit of 6.7 femtomoles, the final protein
residue left on the stainless-steel surface was 35 femtomoles
see Fig. 4b, about 3 log reductions from an initial value of
55 picomoles. This minimum protein residue was found to
depend on the protein detection limit. We replaced in the LIF
system of Fig. 2a the original emission filter Thorlabs,
FEL0500 with an FITC filter Laser2000, FF506-Em02–25
and the original dichroic filter Nikon, 505 nm with a La-
ser2000 filter FF506-Di02–25x36. The detection limit was
found to reduce to 0.84 femtomole as shown in Fig. 10, or
0.17 femtomole/mm2. With the improved protein detection
capability, the minimum protein residue was found to reduce
from 35 to 1.8 femtomoles, or some 4.5 log reduction from
the initial 55 picomoles. This is equivalent to
0.36 femtomole/mm2 or 3.6108 molecules/mm2. With fu-
ture improvement in the protein detection capability, the
minimum protein residue may fall further.
A parallel study on possible physical mechanisms has
also been presented. By interplaying protein reduction kinet-
ics with optical emission spectroscopy, atomic oxygen and
nitride oxide have been shown to play significant roles, pos-
sibly in a synergistic way, in destructing and degrading sur-
face protein. Plasma conditions under which atomic oxygen
and excited NO are most abundant have been shown to be
similar to plasma conditions under which protein reduction is
most effective. Among plasma species not detectable by op-
FIG. 10. Linear correlation of surface protein on fluorescence light intensity
with improved emission and dichroic filters introduced to the LIF system of
Fig. 2a.
074701-8 Deng, Shi, and Kong J. Appl. Phys. 101, 074701 2007
Downloaded 20 Aug 2009 to 158.125.80.71. Redistribution subject to AIP license or copyright; see http://jap.aip.org/jap/copyright.jsp
tical emission spectroscopy, ground-state atomic oxygen and
ground-state NO are likely to have contributed in a not-
insignificant fashion and in a way that supports the primary
contribution of excited atomic oxygen and excited nitride
oxide. This will be discussed in a future article.
ACKNOWLEDGMENTS
The authors would like to acknowledge the generous fi-
nancial support of the Department of Health, UK. They are
also grateful to the advice of and discussion with Dr. P. R.
Richardson, Dr. A. C. Jones, and Dr. J. S. Barton on protein
detection techniques.
1P. Brown, M. Preece, J. P. Brandel, T. Sato, L. McShane, I. Zerr, A.
Fletcher, R. G. Will, M. Pocchiari, N. R. Cashman, J. H. d’Aignaux, L.
Cervenakova, J. Fradkin, L. B. Schonberger, and S. J. Collins, Neurology
55, 1075 2000.
2A. Smith, M. Dickson, J. Aitken, and J. Bagg, J. Hosp. Infect. 51, 233
2002.
3J. R. Roth, Industrial Plasma Engineering: Vol. I. Principles Institute of
Physics, Bristol, 1995, pp. 453–461.
4M. Laroussi, Plasma Processes Polym. 2, 391 2005.
5K. Kelly-Wintenberg, T. C. Montie, C. Brickman, J. R. Roth, A. K. Carr,
K. Sorge, L. C. Wadsworth, and P. P. Y. Tsai, J. Ind. Microbiol. Biotechnol.
20, 69 1998.
6H. W. Herrmann, I. Henins, J. Park, and G. S. Selwyn, Phys. Plasmas 6,
2284 1999.
7N. S. Panikov, S. Paduraru, R. Crowe, P. J. Ricatto, C. Christodoulatos,
and K. Becker, IEEE Trans. Plasma Sci. 30, 1424 2002.
8M. Vleugels, G. Shama, X. Deng, E. Greenacre, T. Brocklehurst, and M.
G. Kong, IEEE Trans. Plasma Sci. 33, 824 2005.
9J. R. Roth, D. M. Sherman, R. B. Gadri, F. Karakaya, Z. Chen, T. C.
Montie, K. Kelly-Wintenberg, and P. Y. Tsai, IEEE Trans. Plasma Sci. 28,
56 2000.
10W. Lai, H. Lai, S. P. Kuo, O. Tarasenko, and K. Levon, Phys. Plasmas 12,
023501 2005.
11X. T. Deng, J. J. Shi, G. Shama, and M. G. Kong, Appl. Phys. Lett. 87,
153901 2005.
12H. Yu, S. Perni, J. J. Shi, D. Z. Wang, M. G. Kong, and G. Shama, J. Appl.
Microbiol. 101, 1323 2006.
13C. Bernard, A. Leduc, J. Barbeau, B. Saoudi, L’H. Yahia, and G. De
Crescenzo, J. Phys. D: Appl. Phys. 39, 3470 2006.
14X. T. Deng, J. J. Shi, and M. G. Kong, Appl. Phys. Lett. 90, 013903
2007.
15S. Perni, X. T. Deng, G. Shama, and M. G. Kong, IEEE Trans. Plasma Sci.
34, 1297 2006.
16H. C. Baxter, G. A. Campbell, A. G. Whittaker, A. C. Jones, A. Aitken, A.
H. Simpson, M. Casey, L. Bountiff, L. Gibbard, and R. L. Baxter, J. Gen.
Virol. 86, 2393 2005.
17X. T. Deng, J. J. Shi, G. Shama, and M. G. Kong, Appl. Phys. Lett. 87,
153901 2005.
18J. L. Walsh, J. J. Shi, and M. G. Kong, Appl. Phys. Lett. 88, 171501
2006.
19V. I. Kovalev, J. S. Barton, P. R. Richardson, and A. C. Jones, presented at
2nd International Conference on Optical and Laser Diagnostics, London,
UK, September 2005.
20P. R. Richardson, A. C. Jones, R. L. Baxter, H. C. Baxter, A. G. Whittaker,
and G. A. Campbell, Proc. SPIE 5502, 291 2004.
21X. T. Deng, J. J. Shi, and M. G. Kong, IEEE Trans. Plasma Sci. 34, 1310
2006.
22M. G. Kong and X. T. Deng, IEEE Trans. Plasma Sci. 31, 7 2003.
23J. J. Shi, X. T. Deng, R. Hall, J. D. Punnett, and M. G. Kong, J. Appl.
Phys. 94, 6303 2003.
24J. J. Shi and M. G. Kong, J. Appl. Phys. 94, 5504 2003.
25M. Laroussi, D. A. Mendis, and M. Rosenberg, New J. Phys. 5, 41 2003.
26P. R. Chalise, S. Perni, G. Shama, B. M. Novac, I. R. Smith, and M. G.
Kong, Appl. Phys. Lett. 89, 153902 2006.
074701-9 Deng, Shi, and Kong J. Appl. Phys. 101, 074701 2007
Downloaded 20 Aug 2009 to 158.125.80.71. Redistribution subject to AIP license or copyright; see http://jap.aip.org/jap/copyright.jsp
